Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection(summary in the thread below)

https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/?fbclid=IwAR0Mie--T2GucwUbsYlSrDOaE4haToXuLZ4-EukbR0R_Q77jlxpyIFhHiYo

1. Use hydroxychloroquine / chloroquine for hospitalized patients with COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL
2. . Use hydroxychloroquine / chloroquine + azithromycin for hospitalized patients with COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL

3. Use lopinavir/ritonavir for hospitalized patients with COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL
4. No corticosteroids for hospitalized patients with COVID-19 pneumonia

5. Corticosteroids for hospitalized patients with ARDS due to COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL
6. Use Tocilizumab for hospitalized patients with COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL

7. Use convalescent plasma for hospitalized patients with COVID-19 IN THE CONTEXT OF A CLINICAL TRIAL

On the research end things are moving INCREDIBLY fast. We are writing protocols, IRBs are reviewing them overnight, we are clearing the usual administrative hurdles with unprecedented speed - all to get the science out to you ASAP. Hold the line, the data is coming!!